Contact this trialFirst, we need to learn more about you.
Lenvatinib for Advanced Thyroid Cancer
Recruiting1 awardPhase 2
New York, New York
This trial is being done to see if lenvatinib is safe and effective in treating patients with a type of thyroid cancer called differentiated thyroid cancer (DTC) that has spread outside of the thyroid gland.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.